The company develops and commercializes technologies to produce and detect DNA globally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. Therapeutic DNA produces high-fidelity synthetic DNA sequences for nucleic acid-based therapeutics. MDx Testing Services provides clinical molecular diagnostics testing, COVID-19 testing, and PCR services. DNA Tagging and Security offers authentication products, portable DNA readers, and consumable test kits. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
| Indicator | Value |
|---|---|
| PER | 100.0 |
| EV/EBITDA | 0.2 |
| Price/Free Cash Flow' | 100.0 |
| ROIC | -% |
| Net Debt/EBITDA | 0.3 |